Proportion of Never-Smoker Non–Small Cell Lung Cancer Patients at Three Diverse Institutions

Background: Approximately 10% to 15% of lung cancer cases in the United States occur in never smokers, but there has been much debate about whether this rate is increasing. To determine whether the proportion of never smokers among lung cancer cases is increasing, we conducted a retrospective study using registries from The University of Texas Southwestern Medical Center, Parkland Hospital, and Vanderbilt University. Methods: Registries were queried for demographic information from 1990 to 2013 including sex, age, stage, and self-reported smoking history. Ten thousand five hundred ninety-three non–small cell lung cancer (NSCLC) case patients and 1510 small cell lung cancer (SCLC) case patients were captured, and logistic regression analysis was performed. All statistical tests were two-sided. Results: The proportion of never-smoker NSCLC patients increased from 8.0% in the years 1990 to 1995 to 14.9% in 2011 to 2013 (P < .001). This increase was also observed using multivariable logistic regression after controlling for sex, stage at diagnosis, and race/ethnicity. The percentage of never smokers among SCLC case patients (1.5% in 1990–1995 to 2.5% in 2011–2013, P = .36) or squamous cell NSCLC case patients did not statistically significantly change during this period. Conclusions: This study demonstrates an increasing proportion of NSCLC patients who have never smoked in a large, diverse patient population between 1990 and 2013. Given that this increase appears independent of sex, stage, and race/ethnicity and also occurred in our county hospital, this trend is unlikely due to changes in referral patterns and suggests that the actual incidence of lung cancer in never smokers is increasing.

[1]  J. Samet Is the Incidence of Adenocarcinoma of the Lung Rising in Never Smokers? , 2017, Journal of the National Cancer Institute.

[2]  A. Nicholson,et al.  49 Increasing incidence of non-smoking lung cancer: presentation of patients with early disease to a tertiary institution in the UK , 2016 .

[3]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[4]  O. Arrieta,et al.  Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox". , 2015, Lung cancer.

[5]  C. Swanton,et al.  APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity. , 2015, Cancer discovery.

[6]  Wei Zhang,et al.  EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma. , 2014, Archives of pathology & laboratory medicine.

[7]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[8]  Anthony J Alberg,et al.  Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[9]  M. Stratton,et al.  Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.

[10]  S. Lam,et al.  Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability , 2012, PloS one.

[11]  Wei Zhou,et al.  East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians , 2011, Chinese journal of cancer.

[12]  Erika Avila-Tang,et al.  Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors , 2009, Clinical Cancer Research.

[13]  Erika Avila-Tang,et al.  Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies , 2008, PLoS medicine.

[14]  G. Guyatt,et al.  Physicians Evidence-Based Clinical Practice Development : American College of Chest Thrombolytic Therapy Guideline Methodology for Antithrombotic and , 2008 .

[15]  J. Minna,et al.  Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.

[16]  Office on Smoking The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[17]  O. Axelson,et al.  Indirect estimates of lung cancer death rates in Italy not attributable to active smoking. , 1993, Epidemiology.

[18]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[19]  J. Enstrom Rising lung cancer mortality among nonsmokers. , 1979, Journal of the National Cancer Institute.